Survival Patterns in United States (US) Medicare Enrollees with Non-CML Myeloproliferative Neoplasms (MPN)

por Price, Gregory L., Davis, Keith L., Karve, Sudeep, Pohl, Gerhardt, Walgren, Richard A.
Publicado 2014

Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers

por Karve, Sudeep J, Price, Gregory L, Davis, Keith L, Pohl, Gerhardt M, Smyth, Emily Nash, Bowman, Lee
Publicado 2014

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

por Davie, Alison, Carter, Gebra Cuyun, Rider, Alex, Pike, James, Lewis, Katie, Bailey, Abigail, Price, Gregory L., Ringeisen, Francois, Pivot, Xavier
Publicado 2020

Evaluating the Utility of Existing Patient-Reported Outcome Scales in Novel Patient Populations with Pancreatic Cancer, Lung Cancer, and Myeloproliferative Neoplasms Using Medicare...

por Ivanova, Jasmina I., Mytelka, Daniel S., Duh, Mei Sheng, Birnbaum, Howard G., Cummings, Alice Kate, San Roman, Alexandra M., Price, Gregory L., Swindle, Ralph W.
Publicado 2013

Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy

por Kaufman, Peter A., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Grischke, Eva‐Maria, Andre, Valerie, Stoffregen, Clemens, Shekarriz, Sarah, Price, Gregory L., Carter, Gebra Cuyun, Sledge, George W.
Publicado 2019

Health‐Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer

por Goetz, Matthew P., Martin, Miguel, Tokunaga, Eriko, Park, In Hae, Huober, Jens, Toi, Masakazu, Stoffregen, Clemens, Shekarriz, Sarah, Andre, Valerie, Gainford, M. Corona, Price, Gregory L., Johnston, Stephen
Publicado 2020

Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study

por Stephenson, Judith J, Gable, Jonathon Colby, Zincavage, Rebekah, Price, Gregory L, Churchill, Collin, Zhu, Emily, Stenger, Keri, Singhal, Mukul, Nepal, Bal, Grabner, Michael, Fisch, Michael J, Debono, David, Geschwender, Amy R, Cuyun Carter, Gebra
Publicado 2021

An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer

por Lim, Elgene, Boyle, Frances, Okera, Meena, Loi, Sherene, Goksu, Sema Sezgin, van Hal, Gertjan, Chapman, Sonya C., Gable, Jonathon Colby, Chen, Yanyun, Price, Gregory L., Hossain, Anwar M., Gainford, M. Corona, Ezquerra, Meritxell Bellet
Publicado 2022

Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study

por Tolaney, Sara M., Beeram, Muralidhar, Beck, J. Thaddeus, Conlin, Alison, Dees, E. Claire, Puhalla, Shannon L., Rexer, Brent N., Burris, Howard A., Jhaveri, Komal, Helsten, Teresa, Becerra, Carlos, Kalinsky, Kevin, Moore, Kathleen N., Manuel, Allison M., Lithio, Andrew, Price, Gregory L., Chapman, Sonya C., Litchfield, Lacey M., Goetz, Matthew P.
Publicado 2022